A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Xtant Medical Holdings, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 694,208 shares of XTNT stock, worth $360,988. This represents 0.0% of its overall portfolio holdings.

Number of Shares
694,208
Previous 703,810 1.36%
Holding current value
$360,988
Previous $443,000 6.55%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.55 - $0.8 $5,281 - $7,681
-9,602 Reduced 1.36%
694,208 $472,000
Q2 2024

Aug 09, 2024

SELL
$0.63 - $1.03 $37,485 - $61,285
-59,500 Reduced 7.79%
703,810 $443,000
Q1 2024

May 13, 2024

BUY
$0.92 - $1.28 $20,608 - $28,672
22,400 Added 3.02%
763,310 $893,000
Q4 2023

Feb 13, 2024

BUY
$1.04 - $1.39 $74,018 - $98,929
71,172 Added 10.63%
740,910 $837,000
Q3 2023

Nov 14, 2023

BUY
$0.78 - $1.35 $56,727 - $98,182
72,728 Added 12.18%
669,738 $737,000
Q2 2023

Aug 11, 2023

SELL
$0.58 - $0.93 $3,363 - $5,394
-5,800 Reduced 0.96%
597,010 $555,000
Q1 2023

May 12, 2023

SELL
$0.59 - $1.18 $2,065 - $4,130
-3,500 Reduced 0.58%
602,810 $384,000
Q4 2022

Feb 13, 2023

SELL
$0.5 - $0.8 $10,450 - $16,720
-20,900 Reduced 3.33%
606,310 $400,000
Q3 2022

Nov 14, 2022

SELL
$0.46 - $0.72 $20,097 - $31,456
-43,690 Reduced 6.51%
627,210 $451,000
Q2 2022

Aug 12, 2022

BUY
$0.47 - $0.7 $2,209 - $3,290
4,700 Added 0.71%
670,900 $349,000
Q1 2022

May 13, 2022

SELL
$0.57 - $0.88 $31,577 - $48,752
-55,400 Reduced 7.68%
666,200 $453,000
Q4 2021

Feb 11, 2022

BUY
$0.56 - $1.26 $22,848 - $51,408
40,800 Added 5.99%
721,600 $404,000
Q3 2021

Nov 12, 2021

SELL
$1.05 - $2.0 $347,760 - $662,400
-331,200 Reduced 32.73%
680,800 $756,000
Q2 2021

Aug 13, 2021

BUY
$1.38 - $2.46 $124,516 - $221,963
90,229 Added 9.79%
1,012,000 $1.65 Million
Q1 2021

May 13, 2021

BUY
$1.23 - $4.33 $361,719 - $1.27 Million
294,081 Added 46.85%
921,771 $2.18 Million
Q4 2020

Feb 10, 2021

BUY
$0.82 - $1.63 $205,821 - $409,133
251,002 Added 66.63%
627,690 $751,000
Q3 2020

Nov 13, 2020

BUY
$0.76 - $1.6 $115,520 - $243,200
152,000 Added 67.65%
376,688 $310,000
Q2 2020

Aug 13, 2020

BUY
$0.62 - $1.74 $84,274 - $236,512
135,927 Added 153.14%
224,688 $202,000
Q1 2020

May 14, 2020

BUY
$0.63 - $1.64 $2,961 - $7,707
4,700 Added 5.59%
88,761 $59,000
Q4 2019

Feb 13, 2020

BUY
$1.55 - $2.89 $5,115 - $9,537
3,300 Added 4.09%
84,061 $134,000
Q3 2019

Nov 13, 2019

BUY
$2.41 - $3.05 $14,701 - $18,605
6,100 Added 8.17%
80,761 $229,000
Q2 2019

Aug 12, 2019

BUY
$2.45 - $3.5 $18,375 - $26,250
7,500 Added 11.17%
74,661 $224,000
Q1 2019

May 14, 2019

BUY
$2.09 - $4.45 $23,226 - $49,452
11,113 Added 19.83%
67,161 $205,000
Q4 2018

Feb 13, 2019

BUY
$1.61 - $4.0 $90,237 - $224,192
56,048 New
56,048 $90,000

Others Institutions Holding XTNT

About Xtant Medical Holdings, Inc.


  • Ticker XTNT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 108,226,000
  • Market Cap $56.3M
  • Description
  • Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...
More about XTNT
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.